{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:21:46Z","timestamp":1784154106356,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.forsciint.2024.112352","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T17:05:01Z","timestamp":1734541501000},"page":"112352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Individual application patterns of Cannabis-based Medicines in Germany \u2013 Descriptive evaluation of a patient survey and discussion from a forensic perspective"],"prefix":"10.1016","volume":"367","author":[{"given":"Marica","family":"Hundertmark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Ihlenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaf","family":"Landschaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"R\u00f6hrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Germerott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora","family":"Wunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2024.112352_bib1","unstructured":"United Nations Office on Drugs and Crime, Word Drug Report - Herbal Cannabis for Medical Use: A spectrum of regulatory Approaches. \u3008https:\/\/www.unodc.org\/res\/WDR-2023\/WDR23_B3_CH3_Medical_Cannabis.pdf\u3009, 2023 (accessed May 05, 2024)."},{"key":"10.1016\/j.forsciint.2024.112352_bib2","unstructured":"K. M\u00fcller-Vahl, F. Grotenhermen, Verschreibungsf\u00e4hige cannabisbasierte Medikamente [Prescribable cannabis-based medicines], Cannabis und Cannabinoide in der Medizin [Cannabis and cannabinoids in medicine], Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin, 2019, pp. 165-186."},{"key":"10.1016\/j.forsciint.2024.112352_bib3","unstructured":"German Bundestag, Gesetz zur \u00c4nderung bet\u00e4ubungsmittelrechtlicher und anderer Vorschriften [Act to Amend Narcotic Drugs Provisions and Other Related Provisions] Bundesgesetzblatt [Federal Law Gazette] I(11) (2017) 403-405."},{"key":"10.1016\/j.forsciint.2024.112352_bib4","unstructured":"Association of German Private Health Insurance Companies, Erstattet die PKV die Kosten f\u00fcr eine Cannabis-Therapie? [Does private health insurance cover the costs of cannabis therapy?]. \u3008https:\/\/www.privat-patienten.de\/arzneien-und-hilfsmittel\/erstattet-die-pkv-die-kosten-fuer-eine-cannabis-therapie\/#:~:text=Medizinalcannabis%20ist%20durch%20das%20neue,die%20PKV%20die%20Kosten%20\u00fcbernimmt\u3009. 2024 (accessed May 05, 2024)."},{"key":"10.1016\/j.forsciint.2024.112352_bib5","article-title":"Medicinal use of different cannabis strains: results from a large prospective survey in Germany","author":"Szejko","year":"2024","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.forsciint.2024.112352_bib6","unstructured":"Federal Institute for Drugs and Medical Devices, Abschlussbericht der Begleiterhebung nach \u00a7 31 Absatz 6 des F\u00fcnften Buches Sozialgesetzbuch zur Verschreibung und Anwendung von Cannabisarzneimitteln [Final report of the accompanying survey in accordance with Section 31 (6) of the Fifth Book of the German Social Insurance Code on the prescription and use of cannabis medicinal products]. \u3008https:\/\/www.bfarm.de\/DE\/Bundesopiumstelle\/Medizinisches-Cannabis\/Begleiterhebung\/_node.html\u3009, 2022 (accessed May 05, 2024)."},{"key":"10.1016\/j.forsciint.2024.112352_bib7","unstructured":"C. Kurz, T. Lau, Begleiterhebung zu medizinischem Cannabis - Bedingt aussagekr\u00e4ftig [Monitoring survey on medicinal cannabis - Conditionally meaningful], Deutsches \u00c4rzteblatt 119, 29-30 (2022) 1290-1291."},{"key":"10.1016\/j.forsciint.2024.112352_bib8","unstructured":"Government of Canada, Frequently Asked Questions - Drug-Impaired Driving Laws. \u3008https:\/\/www.justice.gc.ca\/eng\/cj-jp\/sidl-rlcfa\/qa2-qr2.html\u3009, 2021 (accessed May 05, 2024)."},{"key":"10.1016\/j.forsciint.2024.112352_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103307","article-title":"Medicinal cannabis and driving: the intersection of health and road safety policy","volume":"97","author":"Perkins","year":"2021","journal-title":"Int J. Drug Policy"},{"key":"10.1016\/j.forsciint.2024.112352_bib10","unstructured":"Federal Ministry of Justice, \u00a7 24a Stra\u00dfenverkehrsgesetz [\u00a7 24a Traffic Law]. https:\/\/www.gesetze-im-internet.de\/stvg\/__24a.html#:\u223c:text=\u2009(1)%20Ordnungswidrig%20handelt%2C%20wer,solchen%20Atem%2D%20oder%20Blutalkoholkonzentration%20f\u00fchrt., (accessed May 05, 2024)."},{"key":"10.1016\/j.forsciint.2024.112352_bib11","author":"Gastmeier","year":"2024","journal-title":"Schmerz"},{"key":"10.1016\/j.forsciint.2024.112352_bib12","unstructured":"National Association of Statutory Health Insurance Funds, Sonderbeilage zur GKV-Arzneimittel-Schnellinformation f\u00fcr Deutschland [Monthly Drug Utilisation Information System of the National Association of Statutory Health Insurance Funds]. https:\/\/www.gkv-gamsi.de\/startseite\/startseite.jsp, 2022 (accessed May 05, 2024)."},{"issue":"5","key":"10.1016\/j.forsciint.2024.112352_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11050316","article-title":"Identification of potential distinguishing markers for the use of cannabis-based medicines or street cannabis in serum samples","volume":"11","author":"Scheunemann","year":"2021","journal-title":"Metabolites"},{"issue":"13","key":"10.1016\/j.forsciint.2024.112352_bib14","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00216-022-04026-2","article-title":"Beyond Delta9-tetrahydrocannabinol and cannabidiol: chemical differentiation of cannabis varieties applying targeted and untargeted analysis","volume":"414","author":"Monti","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"issue":"2","key":"10.1016\/j.forsciint.2024.112352_bib15","first-page":"179","article-title":"Von \u201eAmnesia Haze\u201c bis \u201eZour Apple\u201c \u2013 die Vielfalt des (Medizinal-)Cannabis [From \u201cAmnesia Haze\u201c to \u201cZour Apple\u201c - the diversity of (medicinal) cannabis","volume":"91","author":"Hundertmark","year":"2024","journal-title":"Toxichem Krimtech"},{"issue":"4","key":"10.1016\/j.forsciint.2024.112352_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/02791072.2014.944960","article-title":"Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in los angeles","volume":"46","author":"Grella","year":"2014","journal-title":"J. Psychoact. Drugs"},{"issue":"1","key":"10.1016\/j.forsciint.2024.112352_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amepre.2015.05.027","article-title":"Toking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S., 2014","volume":"50","author":"Schauer","year":"2016","journal-title":"Am. J. Prev. Med"},{"issue":"5","key":"10.1016\/j.forsciint.2024.112352_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/16.5.276","article-title":"Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana","volume":"16","author":"Huestis","year":"1992","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112352_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jat\/32.7.470","article-title":"Comparison of Cannabinoid Pharmacokinetic Properties in Occasional and Heavy Users Smoking a Marijuana or Placebo Joint","volume":"32","author":"Toennes","year":"2008","journal-title":"J. Anal. Toxicol."},{"issue":"12","key":"10.1016\/j.forsciint.2024.112352_bib20","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1373\/clinchem.2005.056838","article-title":"Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations","volume":"51","author":"Huestis","year":"2005","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.forsciint.2024.112352_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jat\/bks044","article-title":"Psychomotor performance, subjective and physiological effects and whole blood Delta(9)-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis","volume":"36","author":"Schwope","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112352_bib22","unstructured":"Arbeitsgemeinschaft Cannabis als Medizin e.V., Cannabissorten in Deutschland und ihre Inhaltsstoffe [Cannabis varieties in Germany and their constituents]. \u3008https:\/\/www.arbeitsgemeinschaft-cannabis-medizin.de\/wp-content\/uploads\/2023\/09\/Cannabissorten_Inhaltsstoffe-1.pdf\u3009, 2023 (accessed May 05, 2024)."},{"key":"10.1016\/j.forsciint.2024.112352_bib23","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, Cannabis - the current situation in Europe, European Drug Report 2023: Trends and Developments. \u3008https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2023\/cannabis_en\u3009, 2023 (accessed May 05, 2024)."},{"key":"10.1016\/j.forsciint.2024.112352_bib24","unstructured":"F. Grotenhermen, P. Timte, Cannabissorten in Deutschland [Cannabis varieties in Germany], (2022)."},{"key":"10.1016\/j.forsciint.2024.112352_bib25","unstructured":"Federal Union of German Associations of Pharmacists, Verordnung von Arzneimitteln mit Cannabisbl\u00fcten, -extrakt und Cannabinoiden - Informationen f\u00fcr verschreibende \u00c4rzte\/innen [Prescribing medicinal products containing cannabis flowers, extract and cannabinoids - Information for prescribing physicians], (2017)."},{"key":"10.1016\/j.forsciint.2024.112352_bib26","unstructured":"K. M\u00fcller-Vahl, F. Grotenhermen, Pharmakokinetik der Cannabinoide [Pharmacokinetics of Cannabinoids], Cannabis und Cannabinoide in der Medizin [Cannabis and cannabinoids in medicine], Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin, 2019, pp. 75-83."},{"key":"10.1016\/j.forsciint.2024.112352_bib27","unstructured":"Associations of Statutory Health Insurance Physicians, Cannabisarzneimittel [Cannabis-based medicines]. https:\/\/www.kbv.de\/media\/sp\/WirkstoffAktuell_3-23_Cannabisarzneimittel.pdf, 2023)."},{"key":"10.1016\/j.forsciint.2024.112352_bib28","unstructured":"B. Jung, Cannabis-Vaporisator auf Rezept: Was Apotheker wissen sollten [Cannabis vaporiser on prescription: what pharmacists should know]. \u3008https:\/\/www.deutsche-apotheker-zeitung.de\/news\/artikel\/2019\/03\/01\/cannabis-vaporizer-auf-rezept-noch-kein-routine-hilfsmittel\u3009, 2019 (accessed May 05, 2024)."},{"key":"10.1016\/j.forsciint.2024.112352_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.885655","article-title":"Medicinal cannabis prescribing in Australia: an analysis of trends over the first five years","volume":"13","author":"MacPhail","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.forsciint.2024.112352_bib30","unstructured":"S. Gottschling, T. Herdegen, J. Horlemann, I. Hornke, H.G. Kress, I. Kuhlen, R. Likar, S. Mieke, Expertenkonsens: Medizinischer Einsatz von Cannabinoiden [Expert consensus: Medical use of cannabinoids], (2018)."},{"key":"10.1016\/j.forsciint.2024.112352_bib31","unstructured":"Arbeitsgemeinschaft Cannabis als Medizin e.V., Cannabisbl\u00fcten - Dosierung von Cannabisbl\u00fcten [Cannabis flowers - Doseability of cannabis flowers]. \u3008https:\/\/www.arbeitsgemeinschaft-cannabis-medizin.de\/cannabisbluten\/\u3009, (accessed June 10, 2024)."},{"key":"10.1016\/j.forsciint.2024.112352_bib32","unstructured":"J. Horlemann, N. Sch\u00fcrmann, DGS-Praxisleitlinie - Cannabis in der Schmerzmedizin, Version 2.0 f\u00fcr Fachkreise [DGS Practice Guideline - Cannabis in Pain Medicine, Version 2.0 for healthcare professionals], 2024."},{"key":"10.1016\/j.forsciint.2024.112352_bib33","doi-asserted-by":"crossref","unstructured":"T. Schlereth, Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen, S2k-Leitlinie [Diagnosis and non-interventional treatment of neuropathic pain, S2k guideline]. www.dgn.org\/leitlinien, 2019).","DOI":"10.1007\/s42451-019-00139-8"},{"issue":"3","key":"10.1016\/j.forsciint.2024.112352_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00482-021-00560-7","article-title":"Green Rush \u2013 schlimmer als bef\u00fcrchtet? Daten zur Fehlversorgung mit medizinischem Cannabis","volume":"35","author":"Maier","year":"2021","journal-title":"Schmerz"},{"key":"10.1016\/j.forsciint.2024.112352_bib35","unstructured":"Federal Joint Committee, Beschluss des Gemeinsamen Bundesausschusses \u00fcber eine \u00c4nderung der Arzneimittel-Richtlinie: \u00a7 4a und Abschnitt N \u00a7\u00a7 44 bis 45 (Cannabisarzneimittel) [Decision of the Federal Joint Committee on an amendment to the Medicinal Products Directive: \u00a7 4a and Section N \u00a7\u00a7 44 to 45 (cannabis-based medicines)]. https:\/\/www.g-ba.de\/downloads\/39\u2013261-5915\/2023\u201303-16_AM-RL_Paragraf-4a-Abschnitt-N-Paragrafen-44\u201346-Cannabisarzneimittel_BAnz.pdf, 2023 (accessed May 05, 2024).."},{"key":"10.1016\/j.forsciint.2024.112352_bib36","unstructured":"German Bundestag, Gesetz zum kontrollierten Umgang mit Cannabis und zur \u00c4nderung weiterer Vorschriften (Cannabisgesetz \u2014 CanG) [Act on the Controlled Use of Cannabis and on the Amendment of Further Regulations (Cannabis Law - CanG)], Bundesgesetzblatt [Federal Law Gazette] I(109), 2024."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073824004341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073824004341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T23:42:24Z","timestamp":1739317344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073824004341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"alternative-id":["S0379073824004341"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2024.112352","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individual application patterns of Cannabis-based Medicines in Germany \u2013 Descriptive evaluation of a patient survey and discussion from a forensic perspective","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2024.112352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112352"}}